Skip to the page

Data / Form D filings / Strata Oncology, Inc.

Strata Oncology, Inc.: Form D filings

Strata Oncology, Inc., a company in Ann Arbor, MI, filed 4 Form D notices with the SEC between 2016 and 2024. The latest, on November 22, 2024, reports $6.1 million sold of a $10 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8170 JACKSON RD., SUITE A, Ann Arbor, MI, 48103
Phone
(734) 904-0365
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1668497

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 22, 2024New notice$10,000,000$6,145,297$3,854,70314Nov 8, 2024sec.gov
Nov 4, 2020New notice$10,000,000$5,000,000$5,000,0009Oct 26, 2020sec.gov
May 11, 2018New notice$25,000,000$11,750,001$13,249,9997Apr 30, 2018sec.gov
Mar 4, 2016New notice$12,303,544$6,303,544$6,000,0006Feb 24, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Matthew MartinExecutive Officer
Daniel RhodesExecutive Officer, Director
Keith FlahertyDirector
Christopher O'DonnellDirector
Jeffrey WilliamsExecutive Officer, Director
David RubinDirector
James PavlikDirector
Jan GarfinkleDirector

Other companies in Michigan that filed recently

Every Form D from the week of Nov 18, 2024 · All recent filings in Michigan · All recent Other filings

Read from SEC EDGAR. Amount sold is what Strata Oncology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.